Gynecological

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
C31004A Phase 2, Randomized Study of MLN0128 (a Dual TORC1/2 Inhibitor), MLN0128+MLN1117 (a PI3Kα Inhibitor), Weekly Paclitaxel, or the Combination of Weekly Paclitaxel and MLN0128 in Women With Advanced, Recurrent, or Persistent Endometrial CancerHirte, Dr HalOpenNCT02725268
FORWARD 1A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab soravtansine (IMGN853) Versus Investigator’s Choice of Chemotherapy in Women with Folate Receptor α−positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube CancerHirte, Dr HalOpenNCT02631876
OVC.1A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib
to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian,
fallopian tube, or primary peritoneal cancer
Eiriksson, Dr LuaOpenNCT02446600
B9991010A RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AVELUMAB (MSB0010718C) IN COMBINATION WITH AND/OR FOLLOWING CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED EPITHELIAL OVARIAN CANCERHirte, Dr HalOn holdNCT02718417
PHL-086A Study of XL184 (Cabozantinib) in Endometrial CancerHirte, Dr HalOn holdNCT01815151
Download PDF